Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyaluronic Acid Injection in the Glans Penis Versus Selective Serotonin Reuptake Inhibitors for Lifelong Premature: A Randomized Controlled Trial

NCT06451406 is registered in ClinicalTrials.gov with New Valley University as lead sponsor.

NCT NCT06451406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06451406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyaluronic Acid Injection in the Glans Penis Versus Selective Serotonin Reuptake Inhibitors for Lifelong Premature: A Randomized Controlled Trial
Lead sponsor
New Valley University
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2022
Completion date
June 1, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glans penis, hyaluronic acid, lifelong premature, selective serotonin reuptake inhibitor